Welby

Welby EBITDA per Employee

The EBITDA per Employee of Welby (4438.T) as of Oct 27, 2026 is -11.32 M JPY. In the previous year, EBITDA per Employee was -20.37 M JPY — a change of -44.42% (higher).

EBITDA per Employee

-11.32 MJPY

YoY

-44.42%

Last updated:

EBITDA per Employee of Welby is 2025 -11.32 M JPY. EBITDA per Employee of Welby was 2024 -20.37 M JPY. It decreases by -44.42% higher compared to the previous year.

The Welby EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2018
4.00 M JPY
Jan 1, 2019
-113,025.00 JPY
Jan 1, 2020
-8.29 M JPY
Jan 1, 2021
-3.21 M JPY
Jan 1, 2022
1.52 M JPY
Jan 1, 2023
-12.57 M JPY
Jan 1, 2024
-20.37 M JPY
Jan 1, 2025
-11.32 M JPY
The Welby EBITDA per Employee history
YEAREBITDA per EmployeeYoY
-11.32 MJPY-44.42%
-20.37 MJPY+62.03%
-12.57 MJPY-925.58%
1.52 MJPY-147.47%
-3.21 MJPY-61.32%
-8.29 MJPY+7,236.96%
-113,025.00JPY-102.82%
4.00 MJPY-312.09%
-1.89 MJPY-44.57%
-3.40 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Welby Stock analysis

What does Welby do? Welby, Inc. generates revenue through its disease solution service, developed for pharmaceutical companies to establish patient health record platforms. The company also offers Welby My Carte, a cloud service supporting self-management of patients' living habits for conditions like diabetes and hypertension. Pharmaceutical companies purchase the disease solution service, while patients and healthcare providers utilize Welby My Carte for managing chronic conditions. The firm focuses on medical field applications, targeting pharmaceutical firms and end-users seeking health management tools. The disease solution service involves creating PHR platforms tailored to pharmaceutical companies' needs, while Welby My Carte provides a direct consumer-facing solution for managing health habits. Pharmaceutical companies are the primary B2B buyers, and patients using the service for diabetes or hypertension management represent the end-user segment. The company's revenue streams are derived from both enterprise contracts and consumer subscriptions for its health management tools. Welby is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Welby stock

EBITDA per Employee of Welby is -11.32 M JPY in 2025.

EBITDA per Employee of Welby changed from -20.37 M JPY to -11.32 M JPY, representing a -44.42% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Welby since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Welby historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Welby

All Key Metrics — Welby